Company Number: 13415161

Analysis Date: 2025-07-20 18:29 UTC

1. Risk Rating: HIGH
   The company shows significant negative net current assets and shareholders’ funds in its first reported financial period, suggesting substantial insolvency risk. The lack of positive cash reserves and working capital raises concern over meeting short-term liabilities.

2. Key Concerns:

• Solvency: Net current liabilities of £4,927 against minimal cash (£26) indicate inability to cover immediate debts.
• Operational viability: The company commenced in 2021 but shows no employees and a deficit, implying no current revenue-generating operations.
• Limited financial history: Only one partial accounting period is available with no profit and loss statement, limiting assessment of business performance or funding sources.

3. Positive Indicators:

• Company is active and filing timely accounts and confirmation statements, indicating regulatory compliance so far.
• Backing by significant shareholders with control and voting rights (two LLPs and UCL Business Ltd) suggests institutional or academic support.
• Directors include experienced professionals and academics, which may support future operational development.

4. Due Diligence Notes:

• Investigate current funding arrangements and capital injections since 2021 year-end to understand solvency improvements.
• Review any subsequent financial statements or management accounts for 2022 and 2023 to assess progress toward operational sustainability.
• Clarify business model and commercialization plans given the research and experimental development SIC classification, and confirm intellectual property or assets held.
• Confirm no director disqualifications or governance issues, though none are noted currently.
• Verify future cash flow forecasts and planned milestones to evaluate liquidity risk.